Become an ARMR Insider: https://armrreport.com/
ARMR Report Portfolio Update: We have been building our stock market exposure since 3/23/20 the day the Fed began buying everything in sight. This week we were booking some gains but remain bullish. I will share what we are doing now...
GILD: Remdesivir is a WINNER! Our research indicated this in January and ARMR Portfolios have been long since 1/27 @ $63.83. I will discuss how we are handling this success now
Gold & Silver Update: Classic take down as expected on the last day of the month created a much needed breather. I will share what we expect now.
Q&A: Ask and I shall answer
We will be sharing with you information directly off our trading desk.
Our desire is to help you reduce the noise and manage your investments through the lens of reward vs risk instead of traditional fear vs greed.
You have heard the terms “Risk On” or “Risk Off” but what does that mean and how does it effect your investing portfolio? The ARMR Report has the answers and will help you manage risk to improve your investment results no matter what strategy you employ.
DISCLAIMER: All of ARMRreport, our trades, strategies, and news coverage are based on our opinions alone and are only for educational purposes. You should not take any of this information as guidance for buying or selling any type of investment or security. I am only sharing my biased opinion based off of speculation and personal experience. An individual trader's/investor's results may not be typical and may vary from person to person. It is important to keep in mind that there are risks associated with investing in the stock market and that one can lose all of their investment. Thus, trades/investments should not be based on the opinions of others but by your own research and due diligence.